Dr. Mustafa Barbhuiya completed the Clinical Chemistry Fellowship (2018-2020) at the Department of Pathology and Laboratory Medicine, Penn State University College of Medicine, Hershey. He earned a Doctorate in Biochemistry (2013) from Jiwaji University, Gwalior, India and subsequently completed postdoctoral studies (2013-2018) from Johns Hopkins University School of Medicine, Baltimore, USA. He is broadly trained in clinical biochemistry, clinical laboratory management, medical laboratory sciences, cancer epidemiology, cancer biomarkers, next generation sequencing and mass spectrometry. He is board certified as a clinical chemist and CMS approved high complexity clinical laboratory director. He is also American Society of Clinical Pathology board certified in Molecular Biology and Medical Laboratory Sciences.

He was selected as one of the American Society for Clinical Pathologists’ (ASCP’s) 40 Under Forty 2019. The ‘ASCP 40 under forty’ program recognizes members under the age of 40 for their achievements and leadership qualities that are making an impact on pathology and laboratory medicine. He won several other national awards, serves in the committees of professional bodies like Association of Clinical Scientists, American Association of Clinical Chemistry (AACC) and Clinical Laboratory Standard Institute. He was elected Fellow of Association of Clinical Scientists and Associate Fellow of AACC Academy (formerly National Academy of Clinical Biochemistry).

Dr. Barbhuiya set up a global non-profit organization called the Foundation for Advancement of Essential Diagnostics (FAED) in India (2018) and subsequently in USA (2020). The overall goal of this foundation is to promote and further augment the ‘essential diagnostics list’ published by World Health Organization in context to global public health. FAED aims to provide framework for a strong and functional evidence-based laboratory medicine regulatory system in to maintain and sustain the quality assurance and continuous improvement in the practice of laboratory medicine in low-resource settings in Asia, Latin America and Africa.